GeneDx Holdings Corp. Accounts Payable and Accrued Liabilities, Current
GeneDx Holdings Corp. (WGS) had Accounts Payable and Accrued Liabilities, Current of $42.09 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-03
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $42.09M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $46.56M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $57.65M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $50.33M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $42.09M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $46.56M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $57.65M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $50.33M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $49.24M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $41.86M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $30.98M 10-K · filed 2026-02-23 | $30.04M 10-K · filed 2025-02-20 |
| 2024-09-30 | $56.42M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $51.96M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $32.41M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $37.46M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $38.87M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $54.77M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $69.89M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $84.88M 10-K · filed 2024-02-23 | $38.86M 10-K · filed 2023-03-16 |
| 2022-09-30 | $86.88M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $115.88M 10-Q · filed 2022-08-15 | |
| 2021-12-31 | $20.11M 10-K · filed 2023-03-16 | $64.80M 10-Q · filed 2022-08-15 |
| 2021-06-30 | $2.24M 10-Q · filed 2021-07-21 | |
| 2021-03-31 | $1.49M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $97.12K 10-Q · filed 2021-07-21 | |
| 2020-09-30 | $19.35K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |